Oct 4 NantKwest Inc:
* Financial terms of this co-development are not disclosed
* Development agreement to advance innovative natural killer cell combination immunotherapies for the treatment of cancer
* Altor and Co will exclusively collaborate on development of therapeutic applications combining altor's proprietary IL-15 superagonist
* Altor, Co to also exclusively collaborate single-chain t cell receptor/IL-2 fusion protein products with Co's proprietary NK cell therapy platforms Source text for Eikon: Further company coverage:
Morton County sheriff defends tactics against pipeline protesters
CANNON BALL, N.D., Dec 4 The sheriff of the North Dakota county where thousands of people are protesting a controversial pipeline project defended police tactics after they used water hoses and rubber bullets in a late November confrontation.
UPDATE 1-Saudi, Kuwait expect to restart Neutral Zone oilfields soon -sources
DUBAI, Dec 4 Saudi Arabia and Kuwait are expected to agree this month to resume oil production from the jointly operated oilfields in the Neutral Zone that lies between both countries, industry sources told Reuters on Sunday.